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Background: TAVI is a new percutaneous technique especially for elderly, high-risk patients with AS. More than 10.000 patients have been treated 
with this technique worldwide. The anatomic requirements for Medtronic CoreValve (Medtronic, Minneapolis, USA) implantation (iliac-femoral 
arteries’ diameter >6mm, aortic annulus diameter between 20 and 27 mm) are fulfilled in the majority of patients. However, some patients have 
absolutely no option for peripheral artery access (including trans-axillary access). We therefore devised a new method of TAVI access, described as 
“trans-aortic” and tested it in two patients.
Methods: We implanted in two patients a CoreValve prosthesis via the “trans-aortic” route and recorded adverse events peri-procedurally and 
until hospital discharge. The patients were a 93 year old and a 84 year old woman, both with severe PAOD (peripheral arterial occlusive disease). 
The procedure, briefly, is as follows: A mini-sternotomy was performed, and the ascending aorta was directly punctured under visual and fluoroscopic 
guidance. A 9F sheath was inserted, and the access site was pre-sutured using the Tabaksbeutelnaht (tobacco-pouch suture) technique. Then the 
aortic valve was crossed with a hydrophilic wire and a AL1 catheter. Then, over a pigtail catheter, a stiff wire (Amplatz Super Stiff ST1) was introduced 
in the LV, and over it the 18F sheath was introduced in the ascending aorta. The rest of the procedure took place as usual. At the end, the access 
site was surgically sutured with the pre-positioned sutures. Both patients were extubated shortly after the end of the procedure. The patients were at 
all times “off-pump” and without intra-aortic ballon counterpulsation.
Results: TAVI was successful in both cases, and there were no cases of peri-procedural or in-hospital mortality, stroke or myocardial infarction. The 
patients were mobilized after 4 days, and were discharged home after 7 and 9 days.
Conclusions: In the rare occasion, where due to anatomical reasons a TAVI through the femoral or the subclavian artery is not feasible, a “trans-
aortic” approach, as described, provides a good alternative option.
